2023: Pfizer’s $43 billion acquisition of Seagen is in the books, the company said on Thursday, as it becomes the largest M&A transaction in the biopharma industry since AbbVie snatched up Allergan for $63 billion in 2019.
https://www.fiercepharma.com/pharma/done-deal...y-pipeline
Key takeaway:
"In addition to expanding our portfolio and leading the next generation of cancer breakthroughs, we also expect Seagen to contribute meaningfully to our goal of accelerating near-term and long-term financial growth. (...)
As for the near term, Pfizer said on Wednesday that it anticipates products gained from the Seagen buyout will account for $3.1 billion in revenue in 2024 . By 2030 , Pfizer expects that figure to swell to $10 billion ."
People make up your mind - those numbers are inevitable in a bidding war including several suitors. Stop believing that "it has never been done before crap" and "we will most probably get bought out for 4x our SP" nonsense. Let a bidding war conclude our fair price. But first we need results.
https://www.fiercepharma.com/pharma/done-deal...y-pipeline
Key takeaway:
"In addition to expanding our portfolio and leading the next generation of cancer breakthroughs, we also expect Seagen to contribute meaningfully to our goal of accelerating near-term and long-term financial growth. (...)
As for the near term, Pfizer said on Wednesday that it anticipates products gained from the Seagen buyout will account for $3.1 billion in revenue in 2024 . By 2030 , Pfizer expects that figure to swell to $10 billion ."
People make up your mind - those numbers are inevitable in a bidding war including several suitors. Stop believing that "it has never been done before crap" and "we will most probably get bought out for 4x our SP" nonsense. Let a bidding war conclude our fair price. But first we need results.
11
